STRM.BIO: Seed2Develops non-viral gene delivery platform for in vivo cell engineering and gene therapyOct 4, 2026RoundOSSTRM.BIOCompany profile and funding historySourcesprnewswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesNorth AmericaSeed